← Back to Clinical Trials
Recruiting NCT05629000

NCT05629000 Optimization Strategy of Carotid Artery Stenosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05629000
Status Recruiting
Phase
Sponsor Peking Union Medical College Hospital
Condition Carotid Artery Stenosis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2015-01-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Carotid revascularizationMRI-PWICTA

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2015-01-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about how to utilize multiple evaluation techniques in carotid artery stenosis patients for optimizing assessment of diagnosis and treatment strategy. The main questions it aims to answer are: * Identify best strategy that use multi-modal MRI and CT to assess patients' cerebral lesions and perfusion. * Identify best strategy that use multi-modal MRI, PET-MRI ultrasound and CT to assess components and characters of patients' carotid plaques. Participants will accept imaging examination before and after surgery. And doctors will collect basic characteristics, imaging results and biological samples of patients for analysis.

Eligibility Criteria

Inclusion Criteria: 1. patients with severe stenosis (≥50%) or near-occlusion diagnosed by computed tomographic angiogram; 2. patients received carotid endarterectomy at Peking Union Medical College Hospital Exclusion Criteria: (1) Any contraindication to image examination; (3) refuse to sign the Informed consent.

Contact & Investigator

Central Contact

Zhichao Lai, MD

✉ zhichao_lai@126.com

📞 01069152500

Frequently Asked Questions

Who can join the NCT05629000 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Carotid Artery Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05629000 currently recruiting?

Yes, NCT05629000 is actively recruiting participants. Contact the research team at zhichao_lai@126.com for enrollment information.

Where is the NCT05629000 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT05629000 clinical trial?

NCT05629000 is sponsored by Peking Union Medical College Hospital. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology